Defining & Measuring the Quality of Amylin-Induced Weight Loss

10:00 am - Thursday 3rd December 2026

  • Compare methods for measuring fat mass, lean mass, visceral and subcutaneous adipose tissue, bone and broader metabolic changes
  • Determine which measurements can be aligned from preclinical models through clinical trials to support meaningful comparison
  • Establish what evidence would be needed to demonstrate that any body-composition benefit is specific to a molecule, mechanism or receptor profile

Speakers:

Founder & Chief Executive Officer
Pep2Tango Therapeutics